{"id":2338,"date":"2023-12-11T18:50:40","date_gmt":"2023-12-11T17:50:40","guid":{"rendered":"https:\/\/mikrobiomik.net\/?p=2338"},"modified":"2024-08-29T09:49:20","modified_gmt":"2024-08-29T07:49:20","slug":"early-closure-of-clinical-trial-icd-01","status":"publish","type":"post","link":"https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/","title":{"rendered":"Early closure of clinical trial ICD-01"},"content":{"rendered":"[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1\/1″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_column_text]\"EarlyOn November 15th of this year, with our CRO “Sermes”, we informed to the AEMPS (Spanish Agency of Medicines and Sanitary Products) of the EARLY CLOSURE of the ICD-01 Phase III clinical trial,<\/strong> having reached significant statistical results before completing recruitment, during the second interim analysis.<\/p>\n

ICD-01 is a randomized, controlled, open-label clinical trial in patients with primary or recurrent Clostridioides difficile (CD) infection<\/strong> to evaluate the efficacy and safety of MBK-01 (freeze-dried intestinal microbiota capsules) versus the gold standard antibiotic fidaxomicin, the final report of the trial will be published in January 2024. This trial started recruiting patients in 2021, and 21 hospitals in Spain have been included during this time.<\/p>\n

We have started to prepare the regulatory dossier for our leading product, MBK-01, with the aim of applying to the EMA (European Medicines Agency) for centralized marketing authorization <\/strong> during the second half of 2025. MBK-01 will continue to be supplied under compassionate use until it reaches the market.<\/p>\n

With this news we achieved another important milestone for Mikrobiomik.<\/p>\n

AEMPS official website<\/a>[\/vc_column_text][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none”…<\/p>\n","protected":false},"author":1,"featured_media":2340,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[46,74,70],"tags":[],"class_list":{"0":"post-2338","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-clinical-trials","8":"category-clostridium-difficile","9":"category-news-en"},"yoast_head":"\nEarly closure of clinical trial ICD-01 - Mikrobiomik<\/title>\n<meta name=\"description\" content=\"Mikrobiomik concludes the ICD-01 phase III clinical trial early, and expects its commercialization in the second half of 2024\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Early closure of clinical trial ICD-01 - Mikrobiomik\" \/>\n<meta property=\"og:description\" content=\"Mikrobiomik concludes the ICD-01 phase III clinical trial early, and expects its commercialization in the second half of 2024\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/\" \/>\n<meta property=\"og:site_name\" content=\"Mikrobiomik\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-11T17:50:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-29T07:49:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mikrobiomik.net\/wp-content\/uploads\/ensayo-clinico-ICD-01-mikrobiomik.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"elen9miKK\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"elen9miKK\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/en\\\/early-closure-of-clinical-trial-icd-01\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/en\\\/early-closure-of-clinical-trial-icd-01\\\/\"},\"author\":{\"name\":\"elen9miKK\",\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/#\\\/schema\\\/person\\\/5aab4530d1d35b96f96e85aa3d4ca9c9\"},\"headline\":\"Early closure of clinical trial ICD-01\",\"datePublished\":\"2023-12-11T17:50:40+00:00\",\"dateModified\":\"2024-08-29T07:49:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/en\\\/early-closure-of-clinical-trial-icd-01\\\/\"},\"wordCount\":337,\"publisher\":{\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/en\\\/early-closure-of-clinical-trial-icd-01\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mikrobiomik.net\\\/wp-content\\\/uploads\\\/ensayo-clinico-ICD-01-mikrobiomik.jpg\",\"articleSection\":[\"Clinical trials\",\"Clostridium Difficile\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/en\\\/early-closure-of-clinical-trial-icd-01\\\/\",\"url\":\"https:\\\/\\\/mikrobiomik.net\\\/en\\\/early-closure-of-clinical-trial-icd-01\\\/\",\"name\":\"Early closure of clinical trial ICD-01 - Mikrobiomik\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/en\\\/early-closure-of-clinical-trial-icd-01\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/en\\\/early-closure-of-clinical-trial-icd-01\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mikrobiomik.net\\\/wp-content\\\/uploads\\\/ensayo-clinico-ICD-01-mikrobiomik.jpg\",\"datePublished\":\"2023-12-11T17:50:40+00:00\",\"dateModified\":\"2024-08-29T07:49:20+00:00\",\"description\":\"Mikrobiomik concludes the ICD-01 phase III clinical trial early, and expects its commercialization in the second half of 2024\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/en\\\/early-closure-of-clinical-trial-icd-01\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mikrobiomik.net\\\/en\\\/early-closure-of-clinical-trial-icd-01\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/en\\\/early-closure-of-clinical-trial-icd-01\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mikrobiomik.net\\\/wp-content\\\/uploads\\\/ensayo-clinico-ICD-01-mikrobiomik.jpg\",\"contentUrl\":\"https:\\\/\\\/mikrobiomik.net\\\/wp-content\\\/uploads\\\/ensayo-clinico-ICD-01-mikrobiomik.jpg\",\"width\":1200,\"height\":900,\"caption\":\"Finalizaci\u00f3n ensayo cl\u00ednico ICD-01\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/en\\\/early-closure-of-clinical-trial-icd-01\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/mikrobiomik.net\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Early closure of clinical trial ICD-01\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/#website\",\"url\":\"https:\\\/\\\/mikrobiomik.net\\\/\",\"name\":\"Mikrobiomik\",\"description\":\"Terapias biol\u00f3gicas\",\"publisher\":{\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mikrobiomik.net\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/#organization\",\"name\":\"Mikrobiomik\",\"url\":\"https:\\\/\\\/mikrobiomik.net\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/mikrobiomik.net\\\/wp-content\\\/uploads\\\/mikrobiomik-600.png\",\"contentUrl\":\"https:\\\/\\\/mikrobiomik.net\\\/wp-content\\\/uploads\\\/mikrobiomik-600.png\",\"width\":600,\"height\":171,\"caption\":\"Mikrobiomik\"},\"image\":{\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/mikrobiomik\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mikrobiomik.net\\\/#\\\/schema\\\/person\\\/5aab4530d1d35b96f96e85aa3d4ca9c9\",\"name\":\"elen9miKK\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Early closure of clinical trial ICD-01 - Mikrobiomik","description":"Mikrobiomik concludes the ICD-01 phase III clinical trial early, and expects its commercialization in the second half of 2024","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/","og_locale":"en_US","og_type":"article","og_title":"Early closure of clinical trial ICD-01 - Mikrobiomik","og_description":"Mikrobiomik concludes the ICD-01 phase III clinical trial early, and expects its commercialization in the second half of 2024","og_url":"https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/","og_site_name":"Mikrobiomik","article_published_time":"2023-12-11T17:50:40+00:00","article_modified_time":"2024-08-29T07:49:20+00:00","og_image":[{"width":1200,"height":900,"url":"https:\/\/mikrobiomik.net\/wp-content\/uploads\/ensayo-clinico-ICD-01-mikrobiomik.jpg","type":"image\/jpeg"}],"author":"elen9miKK","twitter_card":"summary_large_image","twitter_misc":{"Written by":"elen9miKK","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/#article","isPartOf":{"@id":"https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/"},"author":{"name":"elen9miKK","@id":"https:\/\/mikrobiomik.net\/#\/schema\/person\/5aab4530d1d35b96f96e85aa3d4ca9c9"},"headline":"Early closure of clinical trial ICD-01","datePublished":"2023-12-11T17:50:40+00:00","dateModified":"2024-08-29T07:49:20+00:00","mainEntityOfPage":{"@id":"https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/"},"wordCount":337,"publisher":{"@id":"https:\/\/mikrobiomik.net\/#organization"},"image":{"@id":"https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/#primaryimage"},"thumbnailUrl":"https:\/\/mikrobiomik.net\/wp-content\/uploads\/ensayo-clinico-ICD-01-mikrobiomik.jpg","articleSection":["Clinical trials","Clostridium Difficile","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/","url":"https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/","name":"Early closure of clinical trial ICD-01 - Mikrobiomik","isPartOf":{"@id":"https:\/\/mikrobiomik.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/#primaryimage"},"image":{"@id":"https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/#primaryimage"},"thumbnailUrl":"https:\/\/mikrobiomik.net\/wp-content\/uploads\/ensayo-clinico-ICD-01-mikrobiomik.jpg","datePublished":"2023-12-11T17:50:40+00:00","dateModified":"2024-08-29T07:49:20+00:00","description":"Mikrobiomik concludes the ICD-01 phase III clinical trial early, and expects its commercialization in the second half of 2024","breadcrumb":{"@id":"https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/#primaryimage","url":"https:\/\/mikrobiomik.net\/wp-content\/uploads\/ensayo-clinico-ICD-01-mikrobiomik.jpg","contentUrl":"https:\/\/mikrobiomik.net\/wp-content\/uploads\/ensayo-clinico-ICD-01-mikrobiomik.jpg","width":1200,"height":900,"caption":"Finalizaci\u00f3n ensayo cl\u00ednico ICD-01"},{"@type":"BreadcrumbList","@id":"https:\/\/mikrobiomik.net\/en\/early-closure-of-clinical-trial-icd-01\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/mikrobiomik.net\/"},{"@type":"ListItem","position":2,"name":"Early closure of clinical trial ICD-01"}]},{"@type":"WebSite","@id":"https:\/\/mikrobiomik.net\/#website","url":"https:\/\/mikrobiomik.net\/","name":"Mikrobiomik","description":"Terapias biol\u00f3gicas","publisher":{"@id":"https:\/\/mikrobiomik.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mikrobiomik.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mikrobiomik.net\/#organization","name":"Mikrobiomik","url":"https:\/\/mikrobiomik.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mikrobiomik.net\/#\/schema\/logo\/image\/","url":"https:\/\/mikrobiomik.net\/wp-content\/uploads\/mikrobiomik-600.png","contentUrl":"https:\/\/mikrobiomik.net\/wp-content\/uploads\/mikrobiomik-600.png","width":600,"height":171,"caption":"Mikrobiomik"},"image":{"@id":"https:\/\/mikrobiomik.net\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/mikrobiomik"]},{"@type":"Person","@id":"https:\/\/mikrobiomik.net\/#\/schema\/person\/5aab4530d1d35b96f96e85aa3d4ca9c9","name":"elen9miKK"}]}},"_links":{"self":[{"href":"https:\/\/mikrobiomik.net\/en\/wp-json\/wp\/v2\/posts\/2338","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mikrobiomik.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mikrobiomik.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mikrobiomik.net\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mikrobiomik.net\/en\/wp-json\/wp\/v2\/comments?post=2338"}],"version-history":[{"count":13,"href":"https:\/\/mikrobiomik.net\/en\/wp-json\/wp\/v2\/posts\/2338\/revisions"}],"predecessor-version":[{"id":2956,"href":"https:\/\/mikrobiomik.net\/en\/wp-json\/wp\/v2\/posts\/2338\/revisions\/2956"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mikrobiomik.net\/en\/wp-json\/wp\/v2\/media\/2340"}],"wp:attachment":[{"href":"https:\/\/mikrobiomik.net\/en\/wp-json\/wp\/v2\/media?parent=2338"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mikrobiomik.net\/en\/wp-json\/wp\/v2\/categories?post=2338"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mikrobiomik.net\/en\/wp-json\/wp\/v2\/tags?post=2338"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}